Crossmark

The role of PSMA radioligands in the diagnosis and treatment of prostate carcinoma

Crossref DOI link: https://doi.org/10.1016/j.remnie.2022.02.001

Published Print: 2022-03

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Rodríguez-Fraile, M.

Tamayo Alonso, P.

Rosales, J.J.

de Arcocha-Torres, María

Caresia-Aróztegui, A.P.

Cózar-Santiago, María Puig

Orcajo-Rincon, Javier

Simó Perdigó, Marc

Delgado Bolton, R.C.

Artigas Guix, C.
License Information

Text and Data Mining valid from 2022-03-01
More Information

This article is maintained by: Elsevier

Article Title: The role of PSMA radioligands in the diagnosis and treatment of prostate carcinoma

Journal Title: Revista Española de Medicina Nuclear e Imagen Molecular (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.remnie.2022.02.001

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.remn.2021.12.002

Content Type: article

Copyright: © 2021 Sociedad Española de Medicina Nuclear e Imagen Molecular. Published by Elsevier España, S.L.U. All rights reserved.